Skip to main content

Showing results for Alzheimer's disease

IU researchers receive $4.8 million grant to study the role of misfolded protein TDP-43 in neurodegenerative diseases

A new $4.8 million grant will support researchers from Indiana University School of Medicine and the Medical Research Council Laboratory of Molecular Biology to study how human neurodegenerative diseases are affected by the misfolding of the protein TDP-43.

IU School of Medicine  |  Apr 23, 2024

High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome

A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome.

IU School of Medicine  |  Mar 29, 2024

Five IU School of Medicine faculty honored among nation's top physician-scientists

Five Indiana University School of Medicine faculty have been recognized among the nation's top physician-scientists as 2024 members of the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).

IU School of Medicine  |  Mar 26, 2024

IU School of Medicine's 2023 NIH funding ranked No. 13 among public universities

Indiana University School of Medicine researchers received over $243 million in total funding from the National Institutes of Health during federal fiscal year 2023 — a more than $54 million increase over the past five years, or 28%.

IU School of Medicine  |  Feb 20, 2024

$3.4 million grant to fund research on brain bleeding, swelling that occurs in quarter of patients who receive Alzheimer’s disease treatments

With the emergence of promising treatments that slow the cognitive decline of Alzheimer’s disease in patients, there are still questions surrounding side effects of the drugs. An Indiana University School of Medicine researcher is among the few neuroscientists investigating these adverse events, which can cause brain swelling and brain bleeding.

IU School of Medicine  |  Feb 14, 2024

Protein found in brain linked to frontotemporal dementia

An international team of researchers including experts at the Indiana University School of Medicine has identified a protein found in the brains of people with frontotemporal dementia (FTD), discovering a new target for potential treatments for the disease.

IU School of Medicine  |  Dec 07, 2023

IU researchers develop new brain network modeling tools to advance Alzheimer's disease research

Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously developed to analyze brains of patients in the clinic—to investigate Alzheimer’s disease progression in preclinical animal models.

IU School of Medicine  |  Nov 30, 2023

IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses

Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer’s disease.

IU School of Medicine  |  Oct 27, 2023

IU researchers identify new gene mutation that alters Alzheimer’s disease risk

A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease.

IU School of Medicine  |  Sep 06, 2023

Statewide project to provide care and support to people living with dementia and their care partners

An Indiana University School of Medicine statewide project in collaboration with Indiana University Health was recently funded to support people living with dementia as well as their family care partners find more support and resources, thanks to a new $686,000 grant from the National Institute on Aging IMPACT Collaboratory.

IU School of Medicine  |  Aug 29, 2023